BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 571456)

  • 1. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
    Jackson DM; Dunstan R; Perrington A
    J Neural Transm; 1979; 44(3):175-86. PubMed ID: 571456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects.
    Anisman H; Ritch M; Sklar LS
    Psychopharmacology (Berl); 1981; 74(3):263-8. PubMed ID: 6791235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
    Dunstan R; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R; Jackson DM
    Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of substance P on the behavioral changes induced by haloperidol in rats.
    Jolicoeur FB; Rondeau DB; Belanger F; Fouriezos G; Barbeau A
    Peptides; 1980; 1(1):103-7. PubMed ID: 6165976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic registration of behaviour related to dopamine and noradrenaline transmission.
    Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1976 Mar; 36(1):181-8. PubMed ID: 177298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine modulation of active ion transport in rabbit corneal epithelium.
    Crosson CE; Beuerman RW; Klyce SD
    Invest Ophthalmol Vis Sci; 1984 Nov; 25(11):1240-5. PubMed ID: 6208162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on the noradrenergic control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1983 Mar; 49(3):358-63. PubMed ID: 6132854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of sympathetic transmission by neuronally-released dopamine.
    Hope W; Majewski H; McCulloch MW; Rand MJ; Story DF
    Br J Pharmacol; 1979 Oct; 67(2):185-92. PubMed ID: 227509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.
    Boulat O; Waldmeier P; Maitre L
    J Neural Transm Gen Sect; 1990; 82(3):181-95. PubMed ID: 2248732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat.
    Al-Shabibi UM; Doggett NS
    J Pharm Pharmacol; 1978 Aug; 30(8):529-31. PubMed ID: 28412
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relationship between arsenic-induced hypothermia and brain monoamines. (2). The roles of noradrenaline and dopamine].
    Kawaguchi M; Tsutsumi S
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):147-54. PubMed ID: 6129183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.